{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/lacerations/","result":{"data":{"firstChapter":{"id":"abcb9c5e-8c70-578e-b2f1-2bfe9e0e6dea","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 57d64d17-14f7-416e-b168-77ebf321e02e --><h1>Lacerations: Summary</h1><!-- end field 57d64d17-14f7-416e-b168-77ebf321e02e -->","htmlStringContent":"<!-- begin item 3b5f3c59-e14a-44b8-b64e-75aadf8a2727 --><!-- begin field 1706fd08-2d83-4512-a8aa-3b3d9fc119d8 --><ul><li>A laceration is a tearing or splitting of the skin commonly caused by blunt trauma, or an incision in the skin caused by a sharp object, such as a knife or broken glass.</li><li>Infection is the most common complication of a laceration. However, there may be injuries to the nerves, blood vessels, muscles, bone, and tendons.</li><li>The risk of infection is high in people with a laceration contaminated with soil, faeces, body fluids, or pus. The risk of infection is increased further with factors such as diabetes, increasing age, and wound length of more than 5 cm.</li><li>A person with a laceration should be assessed to determine whether admission/referral is indicated or if it can be managed in primary care.</li><li>Admission to hospital should be arranged if the person has signs or symptoms of tetanus (generalized rigidity and spasm of skeletal muscles, including lockjaw) and has had a laceration in the previous days or weeks.</li><li>Referral to A&E is recommended if:<ul><li>There is possible vascular, nerve, or tendon damage.</li><li>It is a facial laceration.</li><li>It is a laceration of the palm of the hand with any sign of infection.</li><li>There is associated cellulitis over a joint.</li><li>There is a possible foreign body remaining in the wound after cleaning, including all injuries caused by glass.</li><li>The laceration is complex, widely gaping, or extensively devitalized.</li><li>There is a tetanus-prone wound, which includes wounds that require surgical intervention which has been delayed for more than six hours; wounds which have a significant degree of devitalised tissue or a puncture-type injury (particularly where there has been contact with material likely to contain tetanus spores [for example soil or manure]); wounds containing foreign bodies; compound fractures; and wounds in people who have systemic sepsis.</li></ul></li><li>Primary care management of a laceration involves:<ul><li>Cleaning, closing, and dressing wounds at low risk of infection. Infected wounds or wounds at high risk of infection should be cleaned and dressed initially; secondary closure can be considered after a few days, provided there are no signs of infection.</li><li>Considering the need for antibiotics to treat (or reduce the risk of) infection.</li><li>Considering the need for a booster dose of tetanus vaccine and/or human tetanus immunoglobulin (given in hospital for people with a tetanus-prone wound).</li><li>Giving appropriate information and advice to the person, including that they should seek medical attention if they develop signs of infection; take paracetamol or ibuprofen for pain relief, if needed; and keep the wound clean and dry to reduce the risk of infection.</li><li>Removal of wound closure (if necessary). </li></ul></li></ul><!-- end field 1706fd08-2d83-4512-a8aa-3b3d9fc119d8 --><!-- end item 3b5f3c59-e14a-44b8-b64e-75aadf8a2727 -->","topic":{"id":"bc1075da-03fb-510a-aafc-42f8402c77bb","topicId":"c455b3ad-86f5-4c2b-a00d-ceb66ba46f46","topicName":"Lacerations","slug":"lacerations","aliases":[],"chapters":[{"id":"abcb9c5e-8c70-578e-b2f1-2bfe9e0e6dea","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"b3295eac-08d7-597e-9bbf-240c812490a5","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"0f6da996-76f9-5508-aead-4f7d04fc2910","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3713be7a-1d15-503e-9cdb-6d3afe60f335","slug":"changes","fullItemName":"Changes"},{"id":"d164a0e0-2763-5ec6-8aaa-1f68fe1d381c","slug":"update","fullItemName":"Update"}]},{"id":"e6d917bb-ce9e-58a6-8b13-cf3e389a6aef","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"83820372-5bd1-5e60-a139-cd76615ac683","slug":"goals","fullItemName":"Goals"},{"id":"15606cb7-089f-5a7d-af3f-d4b9c9b0d2be","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1a9aa28b-0708-5c58-843c-05a09196b471","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"682e483f-7847-5e82-be10-969f896d9533","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0db2153f-bcb4-5382-9178-92d651a01c4e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3929f359-184e-53d4-8aca-a4081b967c1a","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"313e7f7d-a625-5b48-a31d-e5f00ca31462","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"0ad26899-0f07-5523-8ea6-17d520df4cc8","slug":"definition","fullItemName":"Definition"},{"id":"e917af1e-ca7f-5ddd-9cb9-1132ce21b4a9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fe57a056-8e82-56fa-bb79-87f037fb4303","slug":"complications","fullItemName":"Complications"}]},{"id":"e01eac70-aab4-50c3-a90e-7b07194bf1c8","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"c1be68cd-346e-504f-b22f-e8352fc5c3f6","slug":"assessment","fullItemName":"Assessment"}]},{"id":"35a250d2-9a3b-5287-8afa-d73dfc12c39b","slug":"management","fullItemName":"Management","subChapters":[{"id":"9c6adc10-cc7f-5820-b2da-874e89c9b72b","slug":"laceration-low-infection-risk","fullItemName":"Scenario: Laceration - low infection risk"},{"id":"496fa19f-131c-5dd3-8be3-ae041478b608","slug":"laceration-high-infection-risk","fullItemName":"Scenario: Laceration - high infection risk"},{"id":"9204ec1a-d022-5955-9f74-6b4eb51bf9a9","slug":"laceration-infected","fullItemName":"Scenario: Laceration - infected"}]},{"id":"ae2f2d25-ab30-53a1-8eff-d3fb8c5994f9","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"ffdfa8df-e6e7-56b4-99c6-dfe62dda65a2","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"f4667375-a12d-57c4-a82a-192c500b41bb","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"8d7c7214-71fc-5171-9875-f310b20c40cb","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"23d49e6f-7a37-5188-8b3f-6b6fdb671019","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"f3f77580-8498-590e-a7c3-0afbee563567","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"8f912e41-1ff8-5fce-b9b4-6b3524e8f79b","slug":"tetanus-booster","fullItemName":"Tetanus booster"}]},{"id":"b1fc897d-bfab-5305-bcf1-70e0f4598e5a","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"18a38028-bff4-54de-948c-9715f3649589","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"0132c748-edac-513b-a351-59a838b07e61","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b4b28cd4-4652-528e-aa28-23f341c6a31e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b86d931b-dadb-55a7-92c8-6cdb81ce5d7f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f6695afc-2f21-5bf7-907b-68a0fb3a77c4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d4ab79d3-d601-5b9b-b2b5-d3256e138671","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bc9ca4ec-c56f-5acc-830c-ccf5c31d5f67","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"bc1075da-03fb-510a-aafc-42f8402c77bb","topicId":"c455b3ad-86f5-4c2b-a00d-ceb66ba46f46","topicName":"Lacerations","slug":"lacerations","aliases":[],"topicSummary":"A laceration is a tearing or splitting of the skin commonly caused by blunt trauma, or an incision caused by a sharp object, such as a knife.","lastRevised":"Last revised in January 2021","nextPlannedReviewBy":"2022-10-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-09","nextPlannedReviewByDisplay":"September 2022","specialities":[{"id":"86ae217e-d675-5678-91c5-7bfbaa88c2f1","name":"Injuries","slug":"injuries"}],"chapters":[{"id":"abcb9c5e-8c70-578e-b2f1-2bfe9e0e6dea","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"b3295eac-08d7-597e-9bbf-240c812490a5","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"0f6da996-76f9-5508-aead-4f7d04fc2910","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3713be7a-1d15-503e-9cdb-6d3afe60f335","slug":"changes","fullItemName":"Changes"},{"id":"d164a0e0-2763-5ec6-8aaa-1f68fe1d381c","slug":"update","fullItemName":"Update"}]},{"id":"e6d917bb-ce9e-58a6-8b13-cf3e389a6aef","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"83820372-5bd1-5e60-a139-cd76615ac683","slug":"goals","fullItemName":"Goals"},{"id":"15606cb7-089f-5a7d-af3f-d4b9c9b0d2be","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1a9aa28b-0708-5c58-843c-05a09196b471","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"682e483f-7847-5e82-be10-969f896d9533","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0db2153f-bcb4-5382-9178-92d651a01c4e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3929f359-184e-53d4-8aca-a4081b967c1a","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"313e7f7d-a625-5b48-a31d-e5f00ca31462","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"0ad26899-0f07-5523-8ea6-17d520df4cc8","slug":"definition","fullItemName":"Definition"},{"id":"e917af1e-ca7f-5ddd-9cb9-1132ce21b4a9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fe57a056-8e82-56fa-bb79-87f037fb4303","slug":"complications","fullItemName":"Complications"}]},{"id":"e01eac70-aab4-50c3-a90e-7b07194bf1c8","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"c1be68cd-346e-504f-b22f-e8352fc5c3f6","slug":"assessment","fullItemName":"Assessment"}]},{"id":"35a250d2-9a3b-5287-8afa-d73dfc12c39b","slug":"management","fullItemName":"Management","subChapters":[{"id":"9c6adc10-cc7f-5820-b2da-874e89c9b72b","slug":"laceration-low-infection-risk","fullItemName":"Scenario: Laceration - low infection risk"},{"id":"496fa19f-131c-5dd3-8be3-ae041478b608","slug":"laceration-high-infection-risk","fullItemName":"Scenario: Laceration - high infection risk"},{"id":"9204ec1a-d022-5955-9f74-6b4eb51bf9a9","slug":"laceration-infected","fullItemName":"Scenario: Laceration - infected"}]},{"id":"ae2f2d25-ab30-53a1-8eff-d3fb8c5994f9","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"ffdfa8df-e6e7-56b4-99c6-dfe62dda65a2","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"f4667375-a12d-57c4-a82a-192c500b41bb","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"8d7c7214-71fc-5171-9875-f310b20c40cb","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"23d49e6f-7a37-5188-8b3f-6b6fdb671019","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"f3f77580-8498-590e-a7c3-0afbee563567","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"8f912e41-1ff8-5fce-b9b4-6b3524e8f79b","slug":"tetanus-booster","fullItemName":"Tetanus booster"}]},{"id":"b1fc897d-bfab-5305-bcf1-70e0f4598e5a","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"18a38028-bff4-54de-948c-9715f3649589","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"0132c748-edac-513b-a351-59a838b07e61","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b4b28cd4-4652-528e-aa28-23f341c6a31e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b86d931b-dadb-55a7-92c8-6cdb81ce5d7f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f6695afc-2f21-5bf7-907b-68a0fb3a77c4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d4ab79d3-d601-5b9b-b2b5-d3256e138671","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bc9ca4ec-c56f-5acc-830c-ccf5c31d5f67","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"bc1075da-03fb-510a-aafc-42f8402c77bb"}},"staticQueryHashes":["3666801979"]}